商標ウォッチ

公開日2025-11-06
公報種別公開国際商標公報
国際登録番号1874254
国際登録日2025-02-14
区分第1類(化学品),第5類(薬剤),第16類(紙),第41類(教育・娯楽),第42類(科学・技術),第44類(医療・農林業)
商品役務Chemical, biological, and biochemical preparations for use in gene delivery technology, namely, nucleic acids, including, coding and non-coding deoxyribonucleic acids, plasmids, vectors, promotors, enhancers and other regulatory sequences, for use in vitro laboratory use; chemical, biological, and biochemical preparations for use in the manufacture of pharmaceutical preparations.,Pharmaceutical preparations for the treatment of neurological and genetic diseases and disorders; chemical, biological, and biochemical preparations for use in gene delivery technology for medical use, namely 全 65 件を表示, nucleic acids, including coding and non-coding deoxyribonucleic acids, plasmids, vectors, promotors, enhancers and other regulatory sequences, for use in in vivo therapeutic use in gene therapy.,Printed publications, namely, books, brochures, informational pamphlets, informational cards, and advertisements being signs and boards of paper in the field of neurological and genetic diseases and disorders.,Education and training services, namely, seminars, providing non-downloadable webinars, and workshops for healthcare professionals, caregivers, patients, and providers in the field of neurological and genetic diseases and disorders; online journals, namely, blogs featuring information on neurological and genetic diseases and disorders.,Pharmaceutical, scientific, and medical research and development in the field of gene therapy manufacturing technology; biomedical and scientific research in the fields of genome editing, gene editing, genome engineering, gene modulation, genetic diseases and disorders, neurological diseases and disorders, gene therapy, and cell therapy; biomedical research in the field of gene therapy design and delivery; gene therapy design and delivery development of biochemical assays; product development in the fields of genetic therapies and effectors to regulate, modulate, and characterize disease states; pharmaceutical research and development in the field of gene therapy; scientific research in the nature of conducting clinical trials for others in the field of gene therapy design and delivery; scientific and medical research, namely, compiling and sharing of patient data for research purposes in the field of neurological and genetic diseases and disorders; medical and scientific research information in the field of neurological and genetic diseases and disorders; providing medical research and scientific research information in the field of neurological and genetic diseases and disorders; providing medical research and scientific research information in the field of gene therapies.,Providing medical services, namely, gene therapy medical services in the field of neurological and genetic diseases and disorders; medical consultations in the field of neurological and genetic diseases and disorders; healthcare services, namely, providing medical and healthcare information in the field of neurological and genetic diseases and disorders, and collecting data and information on neurological and genetic diseases and disorders for screening, diagnosis and treatment purposes, via an online database; medical information services in the field of neurological and genetic diseases and disorder information based on collected patient data and information all for treatment and diagnostic purposes, via an online database.
基礎出願番号98745183,98745195,98745207,98745214,98745222,98745228
基礎出願日2024-09-11,2024-09-11,2024-09-11,2024-09-11,2024-09-11,2024-09-11
基礎出願国US,US,US,US,US,US
出願人Amlogenyx Inc.
OCRテキストAMLOGENYXX
OCRについて

関連商標